COMBINED BRAFV600E AND MEK INHIBITION FOR BRAFV600E-MUTANT ASTROCYTOMAS

被引：0
|
作者：
Zhang, Jie [1 ]
Hariono, Sujatmi [1 ]
Yao, Tsun-Wen [1 ]
Sidhu, Angadpreet [1 ]
Hashizume, Rintaro [1 ]
James, C. David [1 ]
Weiss, William A. [1 ]
Nicolaides, Theodore P. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [1] Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
    Jie Zhang
    Tsun-Wen Yao
    Rintaro Hashizume
    Sujatmi Hariono
    Krister J. Barkovich
    Qi-Wen Fan
    Michael Prados
    C. David James
    William A. Weiss
    Theodore Nicolaides
    [J]. Journal of Neuro-Oncology, 2017, 131 : 495 - 505
  • [2] Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
    Zhang, Jie
    Yao, Tsun-Wen
    Hashizume, Rintaro
    Hariono, Sujatmi
    Barkovich, Krister J.
    Fan, Qi-Wen
    Prados, Michael
    James, C. David
    Weiss, William A.
    Nicolaides, Theodore
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (03) : 495 - 505
  • [3] BRAF-MEK Inhibition Is Effective in BRAFV600E-Mutant Papillary Craniopharyngioma
    不详
    [J]. CANCER DISCOVERY, 2023, 13 (09) : 1960 - 1960
  • [4] SURVIVAL ADVANTAGE WITH EVEROLIMUS (RAD001) COMBINED WITH A SELECTIVE BRAFV600E INHIBITOR IN A XENOGRAFT MODEL OF BRAFV600E-MUTANT PEDIATRIC GLIOMA
    Dasgupta, Tina
    Olow, Aleksandra
    Yang, Xiaodong
    Hashizume, Rintaro
    Mueller, Sabine
    Nicolaides, Theodore
    Kolkowitz, Ilan
    Weiss, William
    Prados, Michael
    Gupta, Nalin
    James, C. David
    Haas-Kogan, Daphne
    [J]. NEURO-ONCOLOGY, 2013, 15 : 43 - 43
  • [5] Resistance to BRAF and MEK inhibitors in BRAFV600E mutant melanoma
    Patel, Hima
    Mishra, Rosalin
    Joan, Garrett
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [6] MAPK inhibition in BRAFV600E CRC
    Kotsiliti, Eleni
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (4) : 201 - 201
  • [7] Combination BRAFV600E Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in BRAFV600E-Mutant Anaplastic Thyroid Cancer
    Gunda, Viswanath
    Ghosh, Chandrayee
    Hu, Jiangnan
    Zhang, Lisa
    Zhang, Ya qin
    Shen, Min
    Kebebew, Electron
    [J]. THYROID, 2023, 33 (10) : 1201 - 1214
  • [8] MAPK inhibition in BRAFV600E CRC
    Eleni Kotsiliti
    [J]. Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 201 - 201
  • [9] Comparative molecular analyses between microsatellite stable BRAFV600E mutant colorectal cancers and BRAFV600E mutant melanomas
    Salem, M. E.
    Xiu, J.
    Puccini, A.
    Grothey, A.
    Goldberg, R. M.
    Hwang, J. J.
    Gatalica, Z.
    Feldman, R.
    Saul, M.
    Korn, W. M.
    Hall, M. J.
    El-Deiry, W.
    Shields, A. F.
    Marshall, J. L.
    Lenz, H. J.
    VanderWalde, A. M.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [10] A Combinatorial Strategy for Targeting BRAFV600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)
    Ghosh, Chandrayee
    Kumar, Suresh
    Kushchayeva, Yevgeniya
    Gaskins, Kelli
    Boufraqech, Myriem
    Wei, Darmood
    Gara, Sudheer Kumar
    Zhang, Lisa
    Zhang, Ya-qin
    Shen, Min
    Mukherjee, Sanjit
    Kebebew, Electron
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (08) : 2022 - 2036
12345